Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABSI Absci Corporation.

Post-Mkt 10-29 16:00:29 EDT

12.10

+0.22

+1.85%

盘后12.10

+0.22+1.85%

16:00 EDT

High12.54	Low11.91	Vol4.28M
Open11.91	D1 Closing11.88	Amplitude5.34%
Mkt Cap2.08B	Tradable Cap1.95B	Total Shares171.61M
T/O52.31M	T/O Rate2.65%	Tradable Shares161.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABSI","market":"US","secType":"STK","nameCN":"Absci Corporation.","latestPrice":12.1,"timestamp":1793303999999,"preClose":11.88,"halted":0,"volume":4276425,"hourTrading":{"tag":"盘后","latestPrice":12.1,"preClose":11.88,"latestTime":"16:00 EDT","volume":19688,"amount":238224.8,"timestamp":1793304022814,"change":0.22,"changeRate":0.018519,"amplitude":0},"delay":0,"changeRate":0.01851851851851842,"floatShares":161244738,"shares":171614010,"eps":-0.799886,"marketStatus":"Post-Mkt","change":0.22,"latestTime":"10-29 16:00:29 EDT","open":11.91,"high":12.5449,"low":11.91,"amount":52305711.102225006,"amplitude":0.053443,"askPrice":12.28,"askSize":4,"bidPrice":12,"bidSize":220,"shortable":3,"etf":0,"ttmEps":-0.799886,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793318400000},"marketStatusCode":4,"adr":0,"listingDate":1626926400000,"exchange":"NASDAQ","adjPreClose":11.88,"preHourTrading":{"tag":"盘前","latestPrice":11.95,"preClose":11.88,"latestTime":"09:29 EDT","volume":33210,"amount":390765.92994,"timestamp":1793280595665,"change":0.07,"changeRate":0.005892,"amplitude":0.035354},"postHourTrading":{"tag":"盘后","latestPrice":12.1,"preClose":11.88,"latestTime":"16:00 EDT","volume":19688,"amount":238224.8,"timestamp":1793304022814,"change":0.22,"changeRate":0.018519,"amplitude":0},"volumeRatio":1.033164,"impliedVol":1.36,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/ABSI","defaultTab":"news","newsList":[{"id":"2679448409","title":"Jefferies Initiates Absci at Buy With $14 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2679448409","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679448409?lang=en_us&edition=fundamental","pubTime":"2026-10-29 19:44","pubTimestamp":1793274297,"startTime":"0","endTime":"0","summary":"Absci (ABSI) has an average rating of buy and mean price target of $14.82, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and res","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ARKG","ABSI","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679792304","title":"Absci initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2679792304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679792304?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:30","pubTimestamp":1793266255,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai initiated coverage of Absci (ABSI) with a Buy rating and $14 price target ABS-201 is approaching two near-term value-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4121","ABSI","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678172676","title":"Absci to Participate in Three Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2678172676","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678172676?lang=en_us&edition=fundamental","pubTime":"2026-10-27 20:07","pubTimestamp":1793102853,"startTime":"0","endTime":"0","summary":"Absci to Participate in Three Investor ConferencesAbsci will participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston on Nov. 10, 2026, with a 1 p.m. ET fireside chat.The 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nNDL76VlsK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BQXX3C00.GBP","BK4139","IE00BN0W2W23.USD","ABSI","BK4539","BK4112","BCDF","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2V16.EUR","SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","SG9999014013.SGD","BK4127","EVR","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3D17.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","ARKG","BK4121","BK4585","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130677738","title":"Wall Street’s Risk-Off Reckoning","url":"https://stock-news.laohu8.com/highlight/detail?id=1130677738","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130677738?lang=en_us&edition=fundamental","pubTime":"2026-10-24 22:11","pubTimestamp":1792851097,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4212.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/4212.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Wall Street’s Risk-Off Reckoning","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARX","RBOT","CRD","CRDU","RXRX","CART","BEG","CRDO","TXG","BE","ABSI","BEZ","BEX","CORT","VG","TEMC","CCI","TEM","TEMT","BEC","BEAM","DNA","CRSP"],"isVideo":true,"video":{"duration":193,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/4212/render_4212_1792850542522.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/4212.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/4212/tts/voiceover_45d83a4ccaeb216d9a4aad40.mp3","isAI":true},"gpt_icon":0},{"id":"2675893351","title":"Press Release: Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2675893351","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675893351?lang=en_us&edition=fundamental","pubTime":"2026-10-13 20:00","pubTimestamp":1791892800,"startTime":"0","endTime":"0","summary":"VANCOUVER, Wash. and NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","AGIX","BK4539","TM","R","VTHR","BK4022","BK4232","ARTY","BK4585","BK4604","QTOC","BK4139","BK4588","BK4121","03160","BK4555","BK4099","ARKG","CHAT","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674872644","title":"Absci Price Target Maintained with a $16.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2674872644","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674872644?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:36","pubTimestamp":1791804960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","ABSI","BK4121","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674745838","title":"H.C. Wainwright Sticks to Its Buy Rating for AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674745838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674745838?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:58","pubTimestamp":1791802694,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on AbSci today and set a price target of $16.00. Ramakanth covers the Health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673705344","title":"BTIG Remains a Buy on AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673705344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673705344?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:57","pubTimestamp":1791284248,"startTime":"0","endTime":"0","summary":"In a report released today, Kambiz Yazdi from BTIG reiterated a Buy rating on AbSci, with a price target of $16.00. Yazdi covers the Healthcare sec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","BK4121","XBI","ABSI","BK4539","BK4585","BK4588","XLV","LABU","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163847","title":"BTIG Keeps Their Buy Rating on AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163847","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163847?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:16","pubTimestamp":1790936201,"startTime":"0","endTime":"0","summary":"BTIG analyst Kambiz Yazdi maintained a Buy rating on AbSci yesterday and set a price target of $16.00. The company’s shares closed yesterday at $10...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","TEMT","NVOH","ABSI","JNJ","ABBV","CRSP","BEAM","VIR","LLYX","NVO","RXRX","AMGN","REGN","NVOC","TEMC","NVOX","BIIB","LLY","PFE","NVS","ABT","RBOT","TXG","MRNA","BNTX","VERU","GERM","MRNX","ELIS","TEM","IDNA","GSKH","LLII","GILD","DNA","SNY","GSK","XBI","MRK","MRNY","AZN","NVAX","ELIL","SBIO"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"1120137912","title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=1120137912","media":"Tech News Roundup","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120137912?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:48","pubTimestamp":1790916487,"startTime":"0","endTime":"0","summary":"","market":"nz","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3039.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","DNA","BEAM","CHRN","RXRX","ABSI","TEM","TEMC","TXG","RBOT","CRSP"],"isVideo":true,"video":{"duration":176,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/render_3039_1790915786173.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/tts/voiceover_6b46a617ba2088f4.mp3","isAI":true},"gpt_icon":0},{"id":"2672768058","title":"H.C. Wainwright Remains a Buy on AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768058?lang=en_us&edition=fundamental","pubTime":"2026-10-01 22:36","pubTimestamp":1790865415,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on AbSci, with a price target of $16.00. Ramakanth ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-absci-absi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABSI","ARKG","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755431","title":"Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755431?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:20","pubTimestamp":1790846446,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","SMMT","BK4137","BK4121","BK4585","LABU","LU0029874061.USD","HCSG","LU0128526141.USD","STRO","BK4581","BK4588","XLV","BK4139","ARKG","XBI","LU2488822045.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460682","title":"Absci Targets Mid-2027 Start for Phase 2 Storyline Trial of ABS-201 in Endometriosis Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460682?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:01","pubTimestamp":1790251264,"startTime":"0","endTime":"0","summary":"Absci targets mid-2027 start for Phase 2 STORYLINE trial of ABS-201 in endometriosis painAbsci outlined a planned Phase 2 STORYLINE trial for ABS-201, an AI-designed antibody for endometriosis-associa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL9N0pHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","ABSI","SG9999014039.USD","IE00BN0W2V16.EUR","BK4121","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","BK4588","IE00BQXX3C00.GBP","LU2210149790.SGD","BK4539","IE00BQXX3F31.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4139","BK4585","BCDF","ARKG","IE00BKPKM429.USD","LU2095319765.USD","BK4112","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460378","title":"Absci Announces Preliminary Details for Phase 2 Storyline™ Trial of AI-Designed Antibody Abs-201™ for Endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460378?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4139","ARKG","ABSI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348460","title":"Absci Corp - Phase 2 Trial Initiation Anticipated in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669348460?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABSI","BK4121","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669855424","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669855424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669855424?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:10","pubTimestamp":1790165442,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entera Bio (ENTX) and AbSci (ABSI) with bullish sent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-348?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENTX","BK4121","LABU","BK4581","XBI","HCSG","BK4585","ABSI","BK4539","BK4588","LU0029874061.USD","BK4137","LU0128526141.USD","XLV","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669910070","title":"Absci Price Target Maintained with a $11.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2669910070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669910070?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:09","pubTimestamp":1790161740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4121","BK4139","BK4539","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530013","title":"Absci Initiated at Outperform by LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530013?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:05","pubTimestamp":1788987900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4121","ARKG","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666826655","title":"Absci initiated with an Outperform at LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666826655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666826655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:25","pubTimestamp":1788949513,"startTime":"0","endTime":"0","summary":"LifeSci Capital initiated coverage of Absci (ABSI) with an Outperform rating and $16 price target Published first on TheFly – the ultimate source f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-initiated-with-an-outperform-at-lifesci-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4121","ABSI","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.absci.com;investors.absci.com","stockEarnings":[{"period":"1week","weight":0.1833},{"period":"1month","weight":0.2518},{"period":"3month","weight":0.555},{"period":"6month","weight":1.4146},{"period":"1year","weight":1.7},{"period":"ytd","weight":2.404}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106318},{"month":2,"riseRate":0.6,"avgChangeRate":0.064917},{"month":3,"riseRate":0.4,"avgChangeRate":-0.085447},{"month":4,"riseRate":0.4,"avgChangeRate":0.03426},{"month":5,"riseRate":0.4,"avgChangeRate":0.033031},{"month":6,"riseRate":0.2,"avgChangeRate":0.025606},{"month":7,"riseRate":0.6,"avgChangeRate":0.127868},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.082694},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.063832},{"month":10,"riseRate":0.833333,"avgChangeRate":0.12867},{"month":11,"riseRate":0.2,"avgChangeRate":-0.134033},{"month":12,"riseRate":0.4,"avgChangeRate":0.218437}],"exchange":"NASDAQ","name":"Absci Corporation.","nameEN":"Absci Corporation."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Absci Corporation.,ABSI,Absci Corporation.股票,Absci Corporation.股票老虎,Absci Corporation.股票老虎国际,Absci Corporation.行情,Absci Corporation.股票行情,Absci Corporation.股价,Absci Corporation.股市,Absci Corporation.股票价格,Absci Corporation.股票交易,Absci Corporation.股票购买,Absci Corporation.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction